![Avencia Sánchez-Mejías](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Avencia Sánchez-Mejías
Director Ejecutivo en Integra Therapeutics SL .
Cargos activos de Avencia Sánchez-Mejías
Empresas | Cargo | Inicio | Fin |
---|---|---|---|
Integra Therapeutics SL
![]() Integra Therapeutics SL Miscellaneous Commercial ServicesCommercial Services Integra Therapeutics SL is a Spanish Barcelona-based company founded in 2020 by Marc Güell and Avencia Sánchez-Mejías, with Avencia Sánchez-Mejías serving as the CEO since then. The company is focused on engineering the next-generation of gene writing tools to cure genetic and oncological diseases with high unmet medical need. Integra Therapeutics is committed to creating new gene writing tools that improve the scope, efficiency, and safety of advanced therapies. | Director Ejecutivo | - | - |
Fundador | - | - |
Historial de carrera de Avencia Sánchez-Mejías
Estadísticas
Internacional
España | 2 |
Operativa
Chief Executive Officer | 1 |
Founder | 1 |
Sectorial
Commercial Services | 2 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
Empresas privadas | 1 |
---|---|
Integra Therapeutics SL
![]() Integra Therapeutics SL Miscellaneous Commercial ServicesCommercial Services Integra Therapeutics SL is a Spanish Barcelona-based company founded in 2020 by Marc Güell and Avencia Sánchez-Mejías, with Avencia Sánchez-Mejías serving as the CEO since then. The company is focused on engineering the next-generation of gene writing tools to cure genetic and oncological diseases with high unmet medical need. Integra Therapeutics is committed to creating new gene writing tools that improve the scope, efficiency, and safety of advanced therapies. | Commercial Services |